In Meril v. Edwards, the Court of Appeal (CoA) of the (European) Unified Patent Court held that permanent injunctions can be withheld when interests of patients are taken into account
Access to Medicine
IGWG 4 – KEI statement on the 2025 European Health Data Spaces Regulation
On Monday, 1 December 2025, Knowledge Ecology International (KEI) delivered the following statement on the 2025 European Health Data Spaces Regulation during the afternoon ession with Relevant Stakeholders which took place at WHO headquarters in Geneva from 16:45–17.15 CET. IGWG… Continue Reading
KEI Comments on Exclusive License to Stage One Immunotherapeutics
On October 20, 2025, Knowledge Ecology International (KEI) submitted comments to the NIH in response to the Federal Register notice titled, “Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors” (90 FR 47782) The… Continue Reading
KEI Comments on Exclusive License of Zika Strain to AARI
On October 14, 2025, Knowledge Ecology International (KEI) provided the NIH with comments regarding the “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy” (90 FR 46414) to Advocate Aurora Research… Continue Reading
KEI Comments to the NIH on Exclusive License to Lysin Therapeutics
On September 24, 2025, Knowledge Ecology International submitted comments to the NIH regarding the “Prospective Grant of an NCI Exclusive Patent License: Use of Anti-Mesothelin Immunotoxins for the Treatment of Mesothelin-Expressing Cancers” (90 FR 43617) to Lysin Therapeutics. Although the… Continue Reading
WHO IGWG3 – KEI’s statement at opening, focuses on transparency, technology transfer and pricing of products, WHO pathogen access and benefit sharing system (PABS) negotiations
On Monday, 3 November 2025, Knowledge Ecology International (KEI) delivered the following intervention at the Third meeting of the open-ended Intergovernmental Working Group on the WHO Pandemic Agreement. Given the significant attacks on the WHO and the importance of restoring… Continue Reading
Delhi High Court Rejects Roche’s Appeal, Paving Way for Affordable Generic Risdiplam
Below is a short note on good news on a court case in India concerning access to risdiplam, a treatment for spinal muscular atrophy (SMA). The note is followed by a statement on the case by Third World Network (TWN),… Continue Reading
Table top simulations and licensing proposals round out country submissions on pathogen access and benefit sharing
On 20 May 2025, the World Health Assembly (WHA) adopted the WHO Pandemic Agreement “pursuant to Article 19 of the Constitution of the World Health Organization” through resolution WHA78.1. While achieving consensus on a number of fronts including pandemic prevention… Continue Reading
KEI Submits FOIA Regarding FDA Orphan Products Grant Program
On July 28, 2025, Knowledge Ecology International (KEI) submitted a Freedom of Information Act request for records concerning the Food and Drug Administration (FDA) Orphan Products Grant Program. The program (administered by the FDA’s Office of Orphan Products Development (OOPD))… Continue Reading
UK-India CETA – Reflections on the IPR chapter (Chapter 13)
On Thursday, 24 July 2025, the United Kingdom published the text of the Comprehensive Economic and Trade Agreement (CETA) between the United Kingdom of Great Britain and Northern Ireland and India and associated documents. The agreement consists of 30 chapters… Continue Reading